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Purpose: Given the burgeoning body of research relating to the psychosocial needs of 
 adolescents and young adults (AYAs) with cancer, this review aimed to evaluate the  psychometric 
properties and appropriateness of the instruments available for use in this unique population. 
Specifically, we reviewed published instruments developed to assess psychological  distress 
(depression, anxiety, stress, and fear of recurrence), psychological growth (resilience, 
 posttraumatic growth, and benefit finding), unmet needs, coping, quality of life, identity, and 
mindfulness-based practices and skills in AYAs with cancer. Given the dearth of validated 
instruments targeting AYAs with cancer, this review also provides a summary of promising 
measures yet to be formally validated in this population.
Methods: Five electronic databases were searched by a team of six researchers, and studies 
involving AYAs (who have or have had cancer) aged 15–30 years, and published between 1982 
and 2012 were reviewed. Of 410 abstracts, 7 instruments were identified as validated in this 
population, with a further 19 identified as promising.
Results: While there are numerous scales to assess psychosocial outcomes in cancer, few have 
been specifically validated for AYAs affected by cancer, particularly in the domains of psychological 
distress, psychological growth, coping, unmet needs, and identity. There are relatively more instru-
ments validated, or promising, for assessment of quality of life than scales for other domains.
Conclusion: In the AYA context, scale selection should be undertaken with thought directed 
towards the characteristics of this sample (eg, developmental maturity, literacy, and social 
context), the practicalities of the setting (eg, available funding and resources, time restrictions, 
and researcher expertise), and the science underlying the scale (eg, theoretical framework and 
psychometric properties). While multiple measures of psychosocial outcomes are frequently 
used in AYAs, further research is clearly needed to provide rigorous evidence of the reliability 
and validity of these tools in young people affected by cancer.
Keywords: adolescents, young adults, psychometric outcomes, psychological outcomes, 
 distress, resilience, coping, quality of life, unmet needs, identity, mindfulness
Introduction
Increasing research interest in the unique experience of cancer in adolescence and 
young adulthood has resulted in a burgeoning number of studies investigating psy-
chosocial outcomes in this population.1 To date, many of these studies have been 
descriptive;  documenting the prevalence of negative constructs, such as psychological 
distress.2 Others have begun to examine more positive outcomes, such as hopeful-
ness and resilience,3 or to investigate the co-occurrence of both negative and positive 
outcomes within the same study.4,5 Interest in the measurement of unmet needs has 
similarly increased over the past 10 to 20 years.6 Evidence indicates that adolescents 
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and young adults (AYAs) affected by, or recovering from, 
cancer are at increased risk of poorer psychological func-
tioning compared to their peers,2 or to children and/or adults 
with cancer.2 Consequently, many researchers have turned 
their attention to developing and evaluating the impact of 
interventions designed to improve psychosocial outcomes 
in this population.7–9 In this context, the availability of age-
appropriate, validated tools to assess psychosocial outcomes 
is paramount.
AYAs affected by cancer are developmentally unique, 
meaning that their needs and experiences may not be fully 
captured by existing instruments developed for children or 
adults.10 Compared to children with cancer, AYAs with cancer 
may be less likely to comply with their treatment  regimen11 
and are more likely to engage in risky activities during or 
after their treatment (eg, smoking, unsafe sex).4,12 These fac-
tors may affect how AYAs transition into well-functioning 
survivorship. Compared to adults with cancer, AYAs may 
be less health literate,13 have a reduced ability to understand 
health risks associated with their condition,12 and place a 
relatively higher importance on their peer relationships.14 
AYAs affected by cancer are also likely to use the Internet 
and social media more often than children and adults,15 are 
less likely to have adequate insurance,16 and are less likely 
to seek medical attention when confronted with concerning 
medical symptoms.17,18 These issues span across cancer types, 
age, gender, and cultural groups, and may affect not only the 
AYA, but also his or her entire family.19 Such age-specific 
individual and social factors are highly likely to shape both 
the nature and severity of the distress that AYAs with cancer 
experience. Consequently, existing measures validated for 
younger children or adults may not be appropriate for the 
AYA age group.
Conducting research on young people with cancer has 
specific challenges. These include, but are not limited to: 
AYAs being less likely to participate in clinical20,21 and 
psychosocial research,22 and being less likely to be treated 
by physicians affiliated with research institutions than other 
populations.16 They are also likely to be spread across 
both pediatric and adult health care institutions, yet make 
up a small proportion of the caseload for either type of 
health care service.16,23 They may use different language 
or jargon than children and adults with cancer, and may 
find it difficult to communicate with their physician about 
sensitive issues.24 Therefore, as the landscape of AYA 
research expands, so does the complexity of selecting 
appropriate measures to assess psychosocial outcomes in 
this population.
When making decisions about which instruments to use 
in AYA psychosocial outcomes research, it is important that 
researchers consider both the potential clinical utility (and 
appropriateness) of a scale, and its psychometric properties. 
Relative to the proportion of studies measuring psychosocial 
outcomes, little research to date has focused on the tools 
used to perform these measurements. In particular, there is 
a lack of research identifying and evaluating age-appropriate 
instruments that are relevant and appealing to young people, 
comparable across studies, and sensitive to change as AYAs 
with cancer progress through treatment into survivorship or 
palliative care.
In this study, therefore, we aimed to review the psy-
chometric properties and appropriateness of the instru-
ments available for use in psychosocial research in AYAs 
who have, or have had, cancer. Specifically, we reviewed 
published instruments developed to assess psychological 
distress (depression, anxiety, stress, and fear of recurrence), 
psychological growth (resilience, posttraumatic growth, 
and benefit finding), unmet needs (including readiness 
for transition to adult health services), coping, quality of 
life (QOL), and identity in AYAs with cancer. In recogni-
tion of the increasing  interest in mindfulness-based work 
with young people,25 we also searched for scales assessing 
mindfulness-based practices and skills in AYAs, such as 
psychological flexibility, defusion, and expansion. Given 
the dearth of scales validated for AYAs with cancer, the 
review also provides a summary of promising instruments 
that have been used in or developed for AYAs with cancer, 
but are yet to be formally validated. The key research ques-
tions considered were:
1. What validated instruments are available to measure 
psychosocial outcomes in AYAs who have, or have had, 
cancer, and what are their psychometric properties?
2. What other promising instruments have been used in or 
developed for AYAs who have, or have had, cancer that 
are yet to be formally validated for this population?
3. What are the gaps, if any, in terms of rigorously assessing 
psychosocial outcomes in young people with cancer?
Methods
The review was conducted according to gold-standard sys-
tematic review procedures.26 This involved determining, a 
priori, a set of inclusion and exclusion criteria; conducting 
a rigorous literature search across five databases using a 
standardized abstract screening and study selection process; 
clearly documenting excluded studies; and using consistent 
data extraction methods.
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Search strategy
Five electronic databases were searched; MEDLINE, MED-
LINE In Process and Non-Indexed Citations, PsycINFO, 
EMBASE, and SWABS, and were limited to human studies 
published in the English language between January 1982 and 
August 2012. In each database, searches for terms defining 
the age group, the disease, the study type, the methodology 
adopted, and the outcomes of interest were run and combined. 
Specifically, the search algorithm used for all domains was: 
[AYA OR “emerging adult” OR adolescen$ OR “young 
adult” OR teen$ OR youth] AND [scale OR questionnaire 
OR measure OR survey] AND [reliability OR validity OR 
validation OR psychometric] AND [oncol$ OR neoplasm OR 
cancer OR tumor OR tumour OR leuk$] AND limits:  [English 
language] AND [humans] AND [year = 1982-current]. 
Domain-specific search terms included:  psychological 
distress [depression OR anxiety OR stress OR fear of recur-
rence], psychological growth [growth OR resilience OR 
“benefit finding” OR hope], coping [coping OR cope OR 
control OR efficacy], QOL [quality of life OR QOL], unmet 
needs [unmet need$ OR transition$], identity [identity] or 
mindfulness [mindful OR psychological flexibility OR value 
OR acceptance OR defusion OR expansion].
inclusion criteria
Studies published in peer-reviewed journals that validated a 
measure of one of this study’s domains of interest for AYAs 
were included in this review. Domains reviewed included 
psychological distress (depression, anxiety, stress, and fear of 
recurrence), psychological growth (resilience, posttraumatic 
growth, and benefit finding), unmet needs (including readi-
ness for transition to adult health services), coping (control 
and  efficacy), QOL, identity, and mindfulness-based practices 
and skills (psychological flexibility, defusion, and expansion) 
in AYAs with cancer. Excluded from the review were instru-
ments assessing other health-related beliefs (eg, body image, 
sexuality, spirituality, and  fertility concerns), health-related 
behaviors (eg, sun protection practices,  smoking behavior, 
and physical activity),  family functioning (including relation-
ships with parents and  siblings), and satisfaction with health 
care and services. Scales solely assessing symptom-related 
aspects, such as fatigue, nausea, or pain, were not included, 
except in cases where these symptom-related aspects formed 
part of a global assessment of QOL.
In order to capture all possibly relevant instruments in 
the cancer context and to increase consistency across the 
field, instruments were included when validated with partici-
pants in the same age range, as defined by Clinton-McHarg 
and  colleagues.27 The target age range was,  therefore, 
exactly 15–30 years; however, scales developed for indi-
viduals younger than 15 years (with an upper age limit of 
15–30 years), and scales developed for individuals older 
than 15 years (but with an upper age limit of 30 years) were 
also included. Where studies included participants outside 
this age range (eg, the study only included adults aged 18+), 
instruments were still included if the study reported sub-
group data on any participants within the target age range 
(eg, if an “adult” study reported data for individuals 18–30 
years old separately from the whole dataset).
The age range criteria specifically targeted studies with 
participants who were currently in the 15–30 age range, 
regardless of their age at diagnosis of cancer. This approach 
was adopted in order to identify measurement scales appro-
priate for patients and other individuals who were currently 
experiencing the AYA developmental stage. Thus,  studies 
that included survivors of pediatric cancer who were aged 
15–30 years were included, while studies assessing out-
comes in survivors of adolescent cancer who were older 
than 30 years when they participated in the research were 
excluded. Studies were included if participants were receiv-
ing active treatment for their illness, were in remission, or 
had been cured of their condition (ie, were in survivorship). 
Only the most recent published report of any given instru-
ment was included.
Study selection
After deduplicating, the resulting 410 abstracts were screened 
by six researchers in two screening teams (PP, FM, ED and CW, 
USD, HW) using the inclusion criteria listed above. Inter-rater 
reliability was 98% (eight disagreements out of 410 abstracts). 
Full-text articles were extracted for all abstracts that either 
appeared eligible to at least one reviewer, or which did not 
yield sufficient information for review, to confirm eligibility. 
Consensus between the researchers in each team was achieved 
by discussing and clarifying details against the full-text article. 
Studies not fitting the inclusion criteria were discarded, with 
the primary reasons for exclusion being: (1) lack of data spe-
cific to the targeted age range; (2) focus on another domain, 
such as attitudes toward smoking or safe sexual practices; (3) 
a medical trial that did not address psychosocial domains; (4) 
a different primary disease, such as diabetes or HIV; and (5) 
the instrument was not available in English.
To augment the electronic search, reference lists of 
included studies and tables of contents of key journals were 
examined manually to identify additional relevant studies. 
This led to the inclusion of a further nine articles.
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Assessment of selected instruments
The team used well-established guidelines28–30 and the 
criteria described in Clinton-McHarg et al27 to evaluate the 
performance of each instrument. Briefly, each instrument was 
assessed for seven domains using the following criteria:
1. Internal reliability – acceptable if the reported Cronbach’s 
alpha coefficient was 0.70 or greater.31
2. Test–retest reliability – acceptable if the correlations 
between the measure administered at two time points 
were .0.7 (Pearson or intraclass correlation coefficient) 
or .0.6 (Cohen’s kappa co-efficient).
3. Content validity – acceptable if the scale had been evalu-
ated logically by a consensus of expert opinions.
4. Convergent and discriminative validity – acceptable 
if correlations between similar conceptual constructs 
were .0.4, and/or correlations between conceptually 
dissimilar constructs were ,0.3. Alternatively, if factor 
analysis was conducted, the measure was acceptable if 
eigenvalues of .1 were achieved for each factor.
5. Responsiveness – acceptable if less than 5% of partici-
pants received the highest and lowest scores (ie, floor 
and/or ceiling effects were minimal) or if the scale was 
able to detect a change with an effect size of .0.5.
6. Acceptability – assessed according to participant burden 
(ie, number of items and time to complete) and missing 
items.
Results
The review identified a total of seven validated instruments 
assessing psychosocial outcomes in AYAs with cancer 
(see Tables 1, 3 and 4), and highlighted a further 19 promis-
ing scales (see Table 2). The findings from each domain are 
summarized below.
Measures of psychological distress
The review identified only one measure, the Uncertainty 
Scale for Kids,32 in the area of depression, anxiety, and stress, 
and this was available in English only. No specific measures 
for assessing fear of cancer recurrence were identified.
A number of other measures were identified as promising, 
namely the Distress Thermometer and the modified Problem 
List for Adolescents and Young Adults;33,34 the Distress Rating 
Scale (modified version of the Distress Thermometer);35 the 
Beck Youth Inventory-II (BYI-II);36 and the Brief Symptom 
Inventory-18 (BSI-18).36 However, the anxiety and depression 
BYI-II scales are rather lengthy (20 items each) and while 
the BSI-18 is considerably shorter, it has been developed for 
individuals 18 years and older. Taking into account that none 
of these measures have been formally validated in AYAs who 
have, or have had, cancer, the Distress Thermometer currently 
appears to be both an accessible and brief option to measure 
psychological distress in this population.
Measures of psychological growth
The review identified two measures of psychological growth 
validated for AYAs with cancer; namely, the Perceived 
 Benefits Scale37 and the Herth Hope Index.38 Both scales 
appear to have acceptable internal consistency, are reason-
ably brief and are available in additional languages (although 
they have not necessarily been validated for AYAs in these 
languages). However, neither scale has been assessed for 
test–retest reliability and are yet to be used in large samples 
of young people affected by cancer.
One scale was identified as promising – the Benefit/ 
Burden scale for Children;39 however, to date, this has 
primarily been used for children and younger adolescents 
with cancer. Other well-known scales, such as the Child and 
Youth Resilience measure (CYRM-28),40 the Child Health 
and Illness Profile-Adolescent Edition (CHIP-AE),41 and the 
Strengths and Difficulties Questionnaire,42 are yet to be vali-
dated in AYAs who have, or have had, cancer. Despite strong 
research interest in posttraumatic growth in cancer,43 there 
was a clear gap in validated scales assessing posttraumatic 
growth in AYAs with cancer, or in survivors.
Measures of unmet needs
The review identified one measure of unmet needs devel-
oped for, and validated among, the AYA population: the 
Cancer Needs Questionnaire for Young People (CNQ-YP).44 
While the CNQ-YP has been validated, it is a relatively new 
measure and has not been validated in populations outside 
Australia. Additionally, many of the unmet needs measures 
developed for the adult population are for specific themes 
or sub-groups and, hence, can be shorter. No specific instru-
ments addressing transitioning from the pediatric to the adult 
hospital system met the criteria for promising or validated. 
Several instruments were found assessing unmet needs in 
other population groups, in particular with specific adult can-
cer groups;45–47 however, none of these had been developed 
for the AYA population nor had specific data regarding young 
people affected by cancer. One paper, which investigated 
satisfaction with information and services provided (which 
was somewhat related to unmet needs), examined the impact 
of age and found some differences in their youngest age 
group of 18–39 year olds, highlighting the need to validate 
such instruments in the AYA age range.48
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Measures of coping
One measure of coping validated in the target population was 
identified, namely, the Pediatric Cancer Coping Scale, which 
was specifically validated in a Taiwanese AYA population.49 
While the scale performed well in Taiwanese young people, 
the English version does not yet appear to have been formally 
validated in AYAs.
Several instruments were identified as promising cop-
ing measures. These include the 14-item Treatment-related 
Coping and Compliance Scale,6 and the Mental Adjustment 
to Cancer Scale, which has been used extensively in cancer, 
and was administered to cancer patients as young as 16 years 
old in one study.50 The Kid-Cope51 has been used in young 
people with cancer in several studies,8,52 and is designed 
to assess cognitive and behavioral coping strategies. The 
Coping Strategies Inventory53 also showed promise, assess-
ing coping thoughts and behaviors in response to a specific 
stressful experience.
Measures of QOL
Of the QOL scales identified, each varied in length (rang-
ing from 14–82 items) and domains measured (five to ten 
domains per scale). Despite the number of QOL scales 
available, only two have been validated across the entire age 
range of AYAs. These include the AYA modified Pediatric 
Quality of Life Inventory Generic Core Scales (23 items) and 
Cancer Module (27 items) (PedsQL-AYA54) and the 41-item 
Quality of Life-Cancer Survivors scale (QOL-CS).55 Both 
of these scales reported excellent internal consistency, good 
convergent/discriminant validity, and were able to signifi-
cantly discriminate between known groups (eg, by symptom 
severity). These two scales, however, differ in their focus; the 
QOL-CS is targeted toward childhood cancer survivors, while 
the PedsQL-AYA incorporates aspects that would be relevant 
to on- or recently off-treatment AYA cancer patients (eg, nau-
sea and treatment anxiety). Only the PedsQL-AYA reported 
conducting focus groups with AYA patients, family members, 
and health or allied health professionals to ensure content 
validity. Neither scale reported test–retest reliability.
Numerous QOL measures also show promise in the 
AYA age group. These scales ranged from the very brief 
Adolescent Quality of Life scale (AQOL, 16 items),56,57 to the 
extensive Impact of Cancer Scale-Childhood Cancer Survi-
vors (IOCS-CS, 82 items),58,59 measured between five to ten 
domains, and have been validated with young people – both 
those undergoing, and who have finished, cancer treatment. 
Most of the promising QOL measures were validated for 
the younger part of the age group (ie, younger adolescents, 
as young as 8 years old). These included the AQOL,56,57 
the  Minneapolis-Manchester Quality of Life Instrument-
 Adolescent form (MMQL-Adolescent),60 the Pediatric Quality 
of Life Inventory-Adolescent form (PedsQL-Adolescent),61 
which formed the basis of the PedsQL-AYA scale,54 the 
Pediatric Cancer Quality of Life Inventory-32-item short 
form62 and Modular Approach,63 and two versions of the 
Perceived Illness Experience Scale.64,65 Two scales have been 
developed for older AYAs: the IOCS-CS,58,59 and the Late 
Adolescent and Young Adult – Survivorship-Related Quality 
of Life measure (LAYA-SRQL).66,67
All promising measures appeared to have acceptable 
internal consistency, and several were able to significantly 
detect differences between young people according to treat-
ment stage (AQOL, MMQL-Adolescent, PCQL-32, PCQL-
Modular, and PIE). However, few of these scales reported 
test–retest reliability or sensitivity to change over time.
Measures of identity
The review did not identify any scales to assess the construct 
of identity, nor were there any suitable for the promising clas-
sification. This finding represents a clear gap given both the 
importance of this construct for the AYA population and the 
potential impact of a life-threatening disease, such as cancer, 
on identity development.14,68
Measures of mindfulness-based  
practice and skills
As with the domain of identity, no validated mindfulness-
based measures were identified from the review and there 
were none that fit the promising classification. Given 
the growing body of literature attesting to the benefits of 
mindfulness-based practices and skills within the cancer 
population,69–71 including AYAs,25 it would seem pertinent 
to have access to scales validated with AYAs with cancer 
measuring this construct.
Discussion
The ways in which clinicians, psychologists and researchers 
think about and define outcomes in young people are varied. 
The present paper evolved out of our own and our colleagues’ 
recognition of the difficulties encountered when selecting the 
most suitable or appropriate outcome measures for conducting 
research in this age group. The review highlights the dearth of 
instruments available to assess psychosocial outcomes in young 
people affected by cancer, and reveals an interesting imbalance 
of available instruments across domains. While some domains 
are understandably  under-represented, given their relatively 
submit your manuscript | www.dovepress.com
Dovepress 
Dovepress
21
Measuring psychosocial outcomes in AYAs with cancer
 
C
lin
ic
al
 O
nc
ol
og
y 
in
 A
do
le
sc
en
ts
 a
nd
 Y
ou
ng
 A
du
lts
 d
ow
nl
oa
de
d 
fr
om
 h
ttp
s:
//w
w
w
.d
ov
ep
re
ss
.c
om
/ b
y 
20
3.
10
.9
1.
78
 o
n 
01
-A
ug
-2
01
8
F
or
 p
er
so
na
l u
se
 o
nl
y.
Powered by TCPDF (www.tcpdf.org)
                               1 / 1
Clinical Oncology in Adolescents and Young Adults 2013:3
Table 4 Psychometric properties of included instruments
Instrument  
(abbreviation)
Internal consistencya Test–retest reliability,  
time periodb
Content validity Convergent/divergent validity Responsiveness Acceptability
Psychological distress
USK32 0.94 r = 0.64, P = 0.005 (1 week) Two panels assessed content validity; one  
of children and adolescents with cancer, the  
other of clinical nurse experts. For 20 of the 
22 original items, the majority of experts  
agreed that the item was “good” or “okay.” 
The remaining 2 items were reworded 
substantially using children’s comments.
Anxiety (r = 0.56, P = 0.001)  
Depressive symptoms (r = 0.59, P , 0.001)  
Cancer knowledge (r = -0.27, P = 0.02)
Highest mean (SD) for item is 2.77 (1.2)  
Lowest mean (SD) for item is 1.65 (1.0)
NA
Psychological growth
PBS37 Positive attitude (0.98);  
positive belief (0.94)
NA Rasch analysis demonstrated that, of the  
38 items in the PBS, 28 items were applicable 
to cancer patients, assessing two distinct 
domains: positive attitude and positive belief.
Analysis of variance on the two subscales demonstrated that  
duration of support group attendance was related to PBS score,  
such that the longer the patient had attended a support group,  
the more positive changes they reported
Mean scores (SD) for patients , 30:  
Positive attitude = 0.9 (0.44);  
positive belief = 0.92 (0.35)
NA
HHindex38 Study 1 (0.84);  
Study 2 (0.78)
Not tested because the stability  
of hope is not well demonstrated  
in cancer populations and patient  
access limited
Use of the HHindex based on the 
Adolescent Resilience Model.  
The model was developed via a series  
of qualitative and quantitative studies  
in AYAs with chronic illnesses,  
including cancer.
Moderate convergent correlations with resilience (self-esteem  
[r = 0.62], self-confidence [0.57], self-transcendence [0.58]) and  
QOL [0.33]. Mod-low discriminant correlations with uncertainty  
in illness [-0.42] and symptom distress [-0.22]. Factor analysis  
supported one-factor solution, final model: NNFi = 0.97,  
CFi = 0.98; iFi = 0.98; RMSEA = 0.04
NA The original 30-item scale 
was reduced to 12 items to 
reduce participant burden 
on AYAs with cancer
Unmet needs
CNQ-YP44 Treatment environment and care (0.98);  
feelings and relationships (0.92); daily  
life (0.94); information and activities  
(0.83); education (0.82); work (0.89)
Weighted kappa ranged from  
0.09 to 0.94, with all but four  
items reaching weighted kappa  
values above 0.60
NA Measure could not discriminate between participants receiving  
treatment and those who had finished treatment (P , 0.05)
Proportion who scored the minimum score  
for each factor ranged from 8.3% to 43%;  
for maximum score: 0–5.1 (large proportion  
of participants had floor effects in education  
(42%) and work (43%))
Easy to follow (80%); clear 
(73%); easy to understand 
(56%); not distressing (78%)
Coping
PCCS49 Study 1 : 0.91 Study 1: 0.86 (2 weeks, n = 45) Qualitative interviews about coping 
experiences of young people with cancer 
were used to develop the PCCS, also 
compared with existing measures. Content 
validity assessed by expert panel. Face 
validity assessed with child patients as well.
Study 1: Construct validity established with KMO = 0.87,  
three factors identified with eigenvalues . 1 (cognitive coping,  
problem-oriented coping, defensive coping). Cognitive coping  
and problem-oriented coping correlated with resilience  
(r = 0.49, 0.61). Defensive coping correlated with anxiety (0.47),  
worry (0.51), physiological (0.30) and social (0.37) anxiety
Proportion of participants who scored the  
minimum scores for each item ranged  
from 2%–36.8%; for the maximum score:  
11.9%–68.2%
NA
Quality of life
AYA modified PedsQL 
Generic Core Scales 
and Cancer Module54
Generic Core Scales: Five of five domains 
 0.70. Total score: 0.95; physical health 
(0.93); psychosocial health (0.92); 
emotional functioning (0.86); social 
functioning (0.81); study/work functioning 
(0.88) Cancer Module: Eight of eight 
domains  0.70; Pain/hurt (0.75); nausea 
(0.89); procedural anxiety (0.85); treatment 
anxiety (0.83); worry (0.76); cognitive 
problems (0.90); perceived physical 
appearance (0.77); communication (0.76)
NA Adapted from AYA modified PedsQL 
Generic Core Scales and Cancer Module. 
Two focus groups conducted: 1st (n = 12) 
AYA patients and family members. 2nd  
(n = 8) health and allied health professionals 
(nurses, doctors, social workers caring 
for AYA patients). Wording modifications 
approved by PedsQL principal developer 
and copyright holder.
Six-factors achieved Eigenvalues . 1.0, (76% of variance).  
Convergent validity with Generic Core Scale: 31/48  
correlations . 0.4 in expected direction
Significantly discriminates between AYAs  
who report mild, moderate, and severe  
symptom severity across all eight subscales.  
Eight of eight subscales showed 8% floor +  
ceiling effects combined (range: 8%–70%)
Minimal missing  
data (#10%)
QOL-CS55 Total scale (0.87); physical (0.81);  
psychological (0.82); fears (0.88);  
social (0.76); spiritual (0.78)
NA NA Cancer Specific Worry Scale; Psychosocial Worry Scale;  
General Health Worry Scale.  
Nine correlations . 0.40
Significantly discriminates between  
participants’ medical history, cancer after-effects,  
gender, income, marital status (P , 0.05  
for 5/6 factors)
Response rate 53%
Notes: aCronbach’s alpha (total scale, subscales). Coefficients reported here are derived either from the AYA population or from the original published validation study 
of each scale. Many Cronbach’s coefficients have later been calculated using scales in different populations, and these provide valuable information about the psychometric 
properties of the scale in different contexts; however, these are not reported here; bintraclass correlation.
Abbreviations: AYA, adolescent and young adults; NA, not assessed or reported.
recent investigation (eg, mindfulness-based practice),69 other 
domains are already being assessed regularly, yet remain poorly 
tested in AYAs with cancer (eg, psychological distress, specifi-
cally anxiety and depression).7 In contrast, QOL instruments 
are relatively well-tested in this population.27
Despite the plethora of research into cancer and psy-
chological distress,72 the endorsement of distress being the 
sixth vital sign of cancer,73 the acknowledgement of the 
prevalence of distress amongst young cancer patients at 
all stages of illness,19 and the growing practice of cancer 
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Table 4 Psychometric properties of included instruments
Instrument  
(abbreviation)
Internal consistencya Test–retest reliability,  
time periodb
Content validity Convergent/divergent validity Responsiveness Acceptability
Psychological distress
USK32 0.94 r = 0.64, P = 0.005 (1 week) Two panels assessed content validity; one  
of children and adolescents with cancer, the  
other of clinical nurse experts. For 20 of the 
22 original items, the majority of experts  
agreed that the item was “good” or “okay.” 
The remaining 2 items were reworded 
substantially using children’s comments.
Anxiety (r = 0.56, P = 0.001)  
Depressive symptoms (r = 0.59, P , 0.001)  
Cancer knowledge (r = -0.27, P = 0.02)
Highest mean (SD) for item is 2.77 (1.2)  
Lowest mean (SD) for item is 1.65 (1.0)
NA
Psychological growth
PBS37 Positive attitude (0.98);  
positive belief (0.94)
NA Rasch analysis demonstrated that, of the  
38 items in the PBS, 28 items were applicable 
to cancer patients, assessing two distinct 
domains: positive attitude and positive belief.
Analysis of variance on the two subscales demonstrated that  
duration of support group attendance was related to PBS score,  
such that the longer the patient had attended a support group,  
the more positive changes they reported
Mean scores (SD) for patients , 30:  
Positive attitude = 0.9 (0.44);  
positive belief = 0.92 (0.35)
NA
HHindex38 Study 1 (0.84);  
Study 2 (0.78)
Not tested because the stability  
of hope is not well demonstrated  
in cancer populations and patient  
access limited
Use of the HHindex based on the 
Adolescent Resilience Model.  
The model was developed via a series  
of qualitative and quantitative studies  
in AYAs with chronic illnesses,  
including cancer.
Moderate convergent correlations with resilience (self-esteem  
[r = 0.62], self-confidence [0.57], self-transcendence [0.58]) and  
QOL [0.33]. Mod-low discriminant correlations with uncertainty  
in illness [-0.42] and symptom distress [-0.22]. Factor analysis  
supported one-factor solution, final model: NNFi = 0.97,  
CFi = 0.98; iFi = 0.98; RMSEA = 0.04
NA The original 30-item scale 
was reduced to 12 items to 
reduce participant burden 
on AYAs with cancer
Unmet needs
CNQ-YP44 Treatment environment and care (0.98);  
feelings and relationships (0.92); daily  
life (0.94); information and activities  
(0.83); education (0.82); work (0.89)
Weighted kappa ranged from  
0.09 to 0.94, with all but four  
items reaching weighted kappa  
values above 0.60
NA Measure could not discriminate between participants receiving  
treatment and those who had finished treatment (P , 0.05)
Proportion who scored the minimum score  
for each factor ranged from 8.3% to 43%;  
for maximum score: 0–5.1 (large proportion  
of participants had floor effects in education  
(42%) and work (43%))
Easy to follow (80%); clear 
(73%); easy to understand 
(56%); not distressing (78%)
Coping
PCCS49 Study 1 : 0.91 Study 1: 0.86 (2 weeks, n = 45) Qualitative interviews about coping 
experiences of young people with cancer 
were used to develop the PCCS, also 
compared with existing measures. Content 
validity assessed by expert panel. Face 
validity assessed with child patients as well.
Study 1: Construct validity established with KMO = 0.87,  
three factors identified with eigenvalues . 1 (cognitive coping,  
problem-oriented coping, defensive coping). Cognitive coping  
and problem-oriented coping correlated with resilience  
(r = 0.49, 0.61). Defensive coping correlated with anxiety (0.47),  
worry (0.51), physiological (0.30) and social (0.37) anxiety
Proportion of participants who scored the  
minimum scores for each item ranged  
from 2%–36.8%; for the maximum score:  
11.9%–68.2%
NA
Quality of life
AYA modified PedsQL 
Generic Core Scales 
and Cancer Module54
Generic Core Scales: Five of five domains 
 0.70. Total score: 0.95; physical health 
(0.93); psychosocial health (0.92); 
emotional functioning (0.86); social 
functioning (0.81); study/work functioning 
(0.88) Cancer Module: Eight of eight 
domains  0.70; Pain/hurt (0.75); nausea 
(0.89); procedural anxiety (0.85); treatment 
anxiety (0.83); worry (0.76); cognitive 
problems (0.90); perceived physical 
appearance (0.77); communication (0.76)
NA Adapted from AYA modified PedsQL 
Generic Core Scales and Cancer Module. 
Two focus groups conducted: 1st (n = 12) 
AYA patients and family members. 2nd  
(n = 8) health and allied health professionals 
(nurses, doctors, social workers caring 
for AYA patients). Wording modifications 
approved by PedsQL principal developer 
and copyright holder.
Six-factors achieved Eigenvalues . 1.0, (76% of variance).  
Convergent validity with Generic Core Scale: 31/48  
correlations . 0.4 in expected direction
Significantly discriminates between AYAs  
who report mild, moderate, and severe  
symptom severity across all eight subscales.  
Eight of eight subscales showed 8% floor +  
ceiling effects combined (range: 8%–70%)
Minimal missing  
data (#10%)
QOL-CS55 Total scale (0.87); physical (0.81);  
psychological (0.82); fears (0.88);  
social (0.76); spiritual (0.78)
NA NA Cancer Specific Worry Scale; Psychosocial Worry Scale;  
General Health Worry Scale.  
Nine correlations . 0.40
Significantly discriminates between  
participants’ medical history, cancer after-effects,  
gender, income, marital status (P , 0.05  
for 5/6 factors)
Response rate 53%
Notes: aCronbach’s alpha (total scale, subscales). Coefficients reported here are derived either from the AYA population or from the original published validation study 
of each scale. Many Cronbach’s coefficients have later been calculated using scales in different populations, and these provide valuable information about the psychometric 
properties of the scale in different contexts; however, these are not reported here; bintraclass correlation.
Abbreviations: AYA, adolescent and young adults; NA, not assessed or reported.
programs  screening for distress in a standardized manner,74 
there are few distress-related measures that have been for-
mally validated in AYAs with cancer. There are also clear 
gaps in the availability of validated unmet needs, coping, 
and psychological growth instruments for AYAs with cancer. 
The development of instruments measuring satisfaction with 
services provided (including psychosocial services) may 
represent the next stage beyond unmet needs measures and 
deserves further exploration. Also striking is the absence of 
measures examining needs or knowledge around the complex 
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issue of transitioning from pediatric to adult care, despite 
clinical and research acknowledgement that transition is a 
key time of need for young people with cancer.75,76
In contrast, the development of QOL measures for AYAs 
with, or recovering from, cancer is more advanced (particu-
larly for younger adolescents). While many of these scales 
incorporate assessment of young peoples’ emotional well-
being and/or functioning, QOL measures are a more distal 
measure of distress than instruments targeting specific psy-
chological domains. This is interesting, given that many inter-
ventions have been developed to target specific psychological 
domains (eg, depression, anxiety, and posttraumatic stress), 
yet many use QOL as their primary outcome measure given 
the lack of other validated alternatives. QOL instruments 
typically comprise a mixture of variables that may cause poor 
QOL (“causal variables,” eg, nausea) and variables that may 
be reflective of poor QOL in general (“indicator variables,” 
eg, distress),77 and so it is possible that psychosocial interven-
tions may be able to change the indicator variables (eg, reduce 
distress) but not the causal variables, as these variables are 
more difficult to change and do not necessarily belong to the 
same latent construct (eg, nausea, communication issues, and 
financial concerns).77 Consequently, global QOL assessment 
comprising a mix of related factors may form a less sensitive 
measure of distress or emotional wellbeing than other more 
specific constructs.
In addition, neither of the two QOL scales validated 
across the AYA age range (PedsQL-AYA and the QOL-CS), 
appear to comprehensively assess AYA-specific issues, such 
as drug/alcohol consumption, fertility, sexuality/intimacy, or 
dating concerns (although there are some scales specifically 
assessing these aspects of the young person’s experience not 
captured here). By contrast, the two promising QOL scales 
identified for older AYAs (IOCS-CS and LAYA-SRQL), do 
include aspects that may be important for the whole AYA 
age range (eg, body image, financial issues, career, and 
sexuality and fertility concerns). These content aspects may 
make these scales uniquely applicable to the developmental 
concerns of AYAs, unlike many of the instruments developed 
for younger adolescents.
implications for future instrument 
development
Finding instruments tested across the entire AYA age range is 
challenging. Both pediatric and adult cancer fields, therefore, 
need to be aware of the unique psychosocial issues of AYAs 
and consider the needs of this population when developing 
pediatric and adult instruments. One solution may be for 
the age groups of potentially useful scales to be extended 
(upwards or downwards) to capture an age span between 15 
and 25 years. Even without extending the age ranges tested 
for existing instruments, presenting validation data for sub-
groups of AYAs separately would be beneficial in order to 
assess whether a general scale is valid and reliable in this spe-
cific age range (eg, presenting subgroup data for 15–18 year 
olds completing children’s scales, or for 18–25 year olds 
completing adult scales, separately). This would ensure that 
scales covering more domains could be used in AYAs and 
may also contribute to reducing the “gap” between AYA 
and adult outcomes23,78 by ensuring that their psychosocial 
functioning can be reliably and validly assessed.
There is also clear need for instruments already com-
monly used in young people with cancer (despite not having 
been validated in this population) to be tested to ensure the 
unique needs of young people are captured by these instru-
ments (eg, the Distress Thermometer and modified Problem 
List for Adolescents and Young Adults;34 Hospital Anxiety 
and Depression Scale;79 the Depression, Anxiety and Stress 
Scale;80 and the K-1081). Across the pool of scales identified 
in all psychosocial domains, there was also a lack of consis-
tent reporting of important validity data such as test–retest 
reliability, responsiveness/sensitivity to change over time, 
and acceptability/relevance of the final scale to consumers 
representing different groups (eg, young people who are on 
versus off cancer treatment).
Consideration should also be given to validating existing 
measures specifically developed for young people with the 
AYA cancer population. For example, mindfulness-based 
practice and skills is an area of increasing interest and 
existing measures, such as the Child and Adolescent Mind-
fulness Measure (CAMM)82 and the Avoidance and Fusion 
Questionnaire for Youth (AFQ-Y),83 could be very useful in 
measuring these important constructs in young people who 
have, or have had, cancer.
Finally, tools specifically developed to assess the unique 
experience of coping with cancer, psychological growth 
(eg, resilience), and identity in AYAs with cancer are also 
urgently needed. So too are instruments developed for 
specific needs groups, including AYAs with culturally and 
linguistically diverse backgrounds (recognized as a critical 
variable in families of children with cancer,84 adults with 
cancer,85,86 and in adolescents with chronic illness87), as well 
as other minority groups (eg, individuals with same-sex 
attraction88).
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implications for future instrument selection
It is unclear how often researchers are using the “best avail-
able” instrument to assess the impact of cancer and/or its 
treatment on young people. Researchers may also not be using 
valid and reliable instruments when assessing the efficacy of 
psychosocial or other interventions developed for this age 
group. Future instrument selection, therefore, must be under-
taken with care and thought directed toward the characteristics 
of the AYA sample (eg, literacy, culture, medical condition), 
the practicalities of the setting (eg, available funding and 
resources, time restrictions, and researcher expertise), the 
specific aspect of the cancer experience to be studied, and the 
science underlying the scale (eg, theoretical framework and 
psychometric properties). Administratively, research instru-
ments need to be easy for clinic staff to distribute, and should 
aim to minimize the burden on young respondents.
Conclusion
The goal of this review was to provide clinicians and research-
ers with concise and workable descriptions of all the published 
instruments assessing psychosocial functioning in the AYA 
oncology setting. Recent research has contributed a great 
deal to our understanding of AYAs’ experiences when being 
treated for,5 or recovering from,89 cancer. However, a broader 
investigation of the complexities of AYA outcomes and their 
measurement is clearly warranted. These findings have impor-
tant implications for how future interventions for this popula-
tion will be developed and evaluated. The limited number of 
available tools in psychosocial domains (other than QOL) may 
be seriously restricting researchers’ abilities to validly and sen-
sitively measure impact, or change, in psychosocial functioning 
in an important cohort of individuals affected by cancer.
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